Visual field loss patterns in dominant and recessive optic atrophy based on OPA1 archetypes

Aims/Purpose: Identification and quantification of visual field loss patterns of dominant optic atrophy forms (ACO2 and AFG3L2 mutations) and recessive optic atrophy form (WFS1 mutation, Wolfram Syndrome, WS) based on machine learning‐obtained archetypes for OPA1‐Dominant Optic Atrophy (DOA). Method...

Full description

Saved in:
Bibliographic Details
Published inActa ophthalmologica (Oxford, England) Vol. 102; no. S279
Main Authors Cascavilla, Maria Lucia, Coutinho, Catarina, Battista, Marco, Zanchetta, Ferdinando, Galzignato, Alice, Lari, Giorgio, Albertini, Stefano, Brotto, Luigi, Nucci, Paolo, Fioresi, Rita, Bandello, Francesco, Barboni, Piero
Format Journal Article
LanguageEnglish
Published Malden Wiley Subscription Services, Inc 01.01.2024
Subjects
Online AccessGet full text
ISSN1755-375X
1755-3768
DOI10.1111/aos.16108

Cover

Abstract Aims/Purpose: Identification and quantification of visual field loss patterns of dominant optic atrophy forms (ACO2 and AFG3L2 mutations) and recessive optic atrophy form (WFS1 mutation, Wolfram Syndrome, WS) based on machine learning‐obtained archetypes for OPA1‐Dominant Optic Atrophy (DOA). Methods: Five patients affected by hereditary optic neuropathies carrying ACO2 gene mutations, 5 with AFG3L2 mutations, and 20 with WFS1 mutations were enrolled. Visual field (VF) tests performed by SITA standard 30–2 or 24–2 Humphrey VF analyzer (Carl Zeiss Meditec, Dublin, CA, USA) were collected for these patients. The VFs of these rare mutations (30% WFS1, 10% ACO2 and 3% AFG3L2 [1]) were decomposed and quantified according to the archetypes (AT) obtained in the unsupervised machine learning model developed for the OPA1 mutation. Results: The archetype analysis (AA)‐model developed for the DOA‐OPA1 mutation is composed of twelve ATs, with the central, the ceco‐central, and the para‐central as the most significant ones. For WS patients, the VF‐decomposition was mostly made up of ATs resembling more severe abnormalities, while for the ACO2 and AFG3L2‐affected patients the most important ATs were similar to the OPA1 cases. Conclusions: The developed AA‐model based on OPA1‐DOA affected patients enabled the decomposition of VFs of more rare optic atrophy mutations. The association of weights to the different ATs for patient‐specific VFs showed to be a possible option to identify and quantify the most important patterns of visual field loss in such particular cases of autosomal dominant or recessive optic neuropathies. A pattern‐specific visual field loss might strengthen the differential diagnosis between OPA1 and other mutations and support future clinical and therapeutic trials. References 1. Rocatcher A, Desquiret‐Dumas V, Charif M, et al. The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands. Brain 2023; 146(2): 455–460. doi: 10.1093/brain/awac395
AbstractList Aims/Purpose: Identification and quantification of visual field loss patterns of dominant optic atrophy forms (ACO2 and AFG3L2 mutations) and recessive optic atrophy form (WFS1 mutation, Wolfram Syndrome, WS) based on machine learning‐obtained archetypes for OPA1‐Dominant Optic Atrophy (DOA).Methods: Five patients affected by hereditary optic neuropathies carrying ACO2 gene mutations, 5 with AFG3L2 mutations, and 20 with WFS1 mutations were enrolled. Visual field (VF) tests performed by SITA standard 30–2 or 24–2 Humphrey VF analyzer (Carl Zeiss Meditec, Dublin, CA, USA) were collected for these patients. The VFs of these rare mutations (30% WFS1, 10% ACO2 and 3% AFG3L2 [1]) were decomposed and quantified according to the archetypes (AT) obtained in the unsupervised machine learning model developed for the OPA1 mutation.Results: The archetype analysis (AA)‐model developed for the DOA‐OPA1 mutation is composed of twelve ATs, with the central, the ceco‐central, and the para‐central as the most significant ones. For WS patients, the VF‐decomposition was mostly made up of ATs resembling more severe abnormalities, while for the ACO2 and AFG3L2‐affected patients the most important ATs were similar to the OPA1 cases.Conclusions: The developed AA‐model based on OPA1‐DOA affected patients enabled the decomposition of VFs of more rare optic atrophy mutations. The association of weights to the different ATs for patient‐specific VFs showed to be a possible option to identify and quantify the most important patterns of visual field loss in such particular cases of autosomal dominant or recessive optic neuropathies. A pattern‐specific visual field loss might strengthen the differential diagnosis between OPA1 and other mutations and support future clinical and therapeutic trials.References1. Rocatcher A, Desquiret‐Dumas V, Charif M, et al. The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands. Brain 2023; 146(2): 455–460. doi: 10.1093/brain/awac395
Aims/Purpose: Identification and quantification of visual field loss patterns of dominant optic atrophy forms (ACO2 and AFG3L2 mutations) and recessive optic atrophy form (WFS1 mutation, Wolfram Syndrome, WS) based on machine learning‐obtained archetypes for OPA1‐Dominant Optic Atrophy (DOA). Methods: Five patients affected by hereditary optic neuropathies carrying ACO2 gene mutations, 5 with AFG3L2 mutations, and 20 with WFS1 mutations were enrolled. Visual field (VF) tests performed by SITA standard 30–2 or 24–2 Humphrey VF analyzer (Carl Zeiss Meditec, Dublin, CA, USA) were collected for these patients. The VFs of these rare mutations (30% WFS1, 10% ACO2 and 3% AFG3L2 [1]) were decomposed and quantified according to the archetypes (AT) obtained in the unsupervised machine learning model developed for the OPA1 mutation. Results: The archetype analysis (AA)‐model developed for the DOA‐OPA1 mutation is composed of twelve ATs, with the central, the ceco‐central, and the para‐central as the most significant ones. For WS patients, the VF‐decomposition was mostly made up of ATs resembling more severe abnormalities, while for the ACO2 and AFG3L2‐affected patients the most important ATs were similar to the OPA1 cases. Conclusions: The developed AA‐model based on OPA1‐DOA affected patients enabled the decomposition of VFs of more rare optic atrophy mutations. The association of weights to the different ATs for patient‐specific VFs showed to be a possible option to identify and quantify the most important patterns of visual field loss in such particular cases of autosomal dominant or recessive optic neuropathies. A pattern‐specific visual field loss might strengthen the differential diagnosis between OPA1 and other mutations and support future clinical and therapeutic trials. References 1. Rocatcher A, Desquiret‐Dumas V, Charif M, et al. The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands. Brain 2023; 146(2): 455–460. doi: 10.1093/brain/awac395
Abstract only
Author Cascavilla, Maria Lucia
Battista, Marco
Zanchetta, Ferdinando
Galzignato, Alice
Brotto, Luigi
Lari, Giorgio
Albertini, Stefano
Barboni, Piero
Bandello, Francesco
Nucci, Paolo
Coutinho, Catarina
Fioresi, Rita
Author_xml – sequence: 1
  givenname: Maria Lucia
  surname: Cascavilla
  fullname: Cascavilla, Maria Lucia
  organization: IRCCS San Raffaele Hospital
– sequence: 2
  givenname: Catarina
  surname: Coutinho
  fullname: Coutinho, Catarina
  organization: Studio Oculistico D'Azeglio
– sequence: 3
  givenname: Marco
  surname: Battista
  fullname: Battista, Marco
  organization: IRCCS San Raffaele Hospital
– sequence: 4
  givenname: Ferdinando
  surname: Zanchetta
  fullname: Zanchetta, Ferdinando
  organization: University of Bologna
– sequence: 5
  givenname: Alice
  surname: Galzignato
  fullname: Galzignato, Alice
  organization: Studio Oculistico D'Azeglio
– sequence: 6
  givenname: Giorgio
  surname: Lari
  fullname: Lari, Giorgio
  organization: IRCCS San Raffaele Hospital
– sequence: 7
  givenname: Stefano
  surname: Albertini
  fullname: Albertini, Stefano
  organization: IRCCS San Raffaele Hospital
– sequence: 8
  givenname: Luigi
  surname: Brotto
  fullname: Brotto, Luigi
  organization: University of Milan
– sequence: 9
  givenname: Paolo
  surname: Nucci
  fullname: Nucci, Paolo
  organization: University of Milan
– sequence: 10
  givenname: Rita
  surname: Fioresi
  fullname: Fioresi, Rita
  organization: University of Bologna
– sequence: 11
  givenname: Francesco
  surname: Bandello
  fullname: Bandello, Francesco
  organization: IRCCS San Raffaele Hospital
– sequence: 12
  givenname: Piero
  surname: Barboni
  fullname: Barboni, Piero
  organization: Studio Oculistico D'Azeglio
BookMark eNp1kE1LxDAQhoMouLt68B8EPHnobpK2aXNcFr9gYQU_EDyEtJmwWbpJTbpK_73VijfnMnN4Zob3maJj5x0gdEHJnA61UD7OKaekPEITWuR5kha8PP6b89dTNI1xRwinnGcT9PZi40E12FhoNG58jLhVXQfBRWwd1n5vnXIdVk7jADXEaD8A-7azNVZd8O22x5WKoLF3ePOwpFiFegtd30I8QydGNRHOf_sMPd9cP63ukvXm9n61XCc1JaxMjEgL4JVKK5GVxAhlNKtEWmoKFSVQq8xUkBKjKRdZyiAjVINmjAnG8kLTdIYux7tt8O8HiJ3c-UNww0uZklLwvBCcDdTVSNVhSBnAyDbYvQq9pER-u5ODO_njbmAXI_tpG-j_B-Vy8zhufAHixnJ5
ContentType Journal Article
Copyright 2024 The Authors Acta Ophthalmologica © 2024 Acta Ophthalmologica Scandinavica Foundation
Copyright © 2024 Acta Ophthalmologica Scandinavica Foundation
Copyright_xml – notice: 2024 The Authors Acta Ophthalmologica © 2024 Acta Ophthalmologica Scandinavica Foundation
– notice: Copyright © 2024 Acta Ophthalmologica Scandinavica Foundation
DBID AAYXX
CITATION
7TK
DOI 10.1111/aos.16108
DatabaseName CrossRef
Neurosciences Abstracts
DatabaseTitle CrossRef
Neurosciences Abstracts
DatabaseTitleList Neurosciences Abstracts

CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1755-3768
EndPage n/a
ExternalDocumentID 10_1111_aos_16108
AOS16108
Genre abstract
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
P6G
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
7TK
ID FETCH-LOGICAL-c1028-f937e6ba3b9480f9afd2b938d1eb10eca4fbe30fd169432e401ded22292257d13
IEDL.DBID DR2
ISSN 1755-375X
IngestDate Tue Oct 07 06:34:47 EDT 2025
Wed Oct 01 02:37:41 EDT 2025
Wed Jan 22 17:15:14 EST 2025
IsPeerReviewed true
IsScholarly true
Issue S279
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1028-f937e6ba3b9480f9afd2b938d1eb10eca4fbe30fd169432e401ded22292257d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
PQID 3089657962
PQPubID 1036384
PageCount 1
ParticipantIDs proquest_journals_3089657962
crossref_primary_10_1111_aos_16108
wiley_primary_10_1111_aos_16108_AOS16108
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2024
2024-01-00
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: January 2024
PublicationDecade 2020
PublicationPlace Malden
PublicationPlace_xml – name: Malden
PublicationTitle Acta ophthalmologica (Oxford, England)
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
SSID ssj0061664
Score 2.3808296
Snippet Aims/Purpose: Identification and quantification of visual field loss patterns of dominant optic atrophy forms (ACO2 and AFG3L2 mutations) and recessive optic...
Abstract only
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
SubjectTerms ACO2 gene
Atrophy
Clinical trials
Decomposition
Differential diagnosis
Learning algorithms
Machine learning
Mutation
Neuropathy
Optic atrophy
Optic neuropathy
Point mutation
Visual field
Title Visual field loss patterns in dominant and recessive optic atrophy based on OPA1 archetypes
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faos.16108
https://www.proquest.com/docview/3089657962
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1755-3768
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0061664
  issn: 1755-375X
  databaseCode: ABDBF
  dateStart: 20080201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1755-3768
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0061664
  issn: 1755-375X
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1755-375X
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1755-3768
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0061664
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED-GD-KL3-J0jiA--NLRz5ji0xDHVOZEnQwUStIkIEo77OaDf72XtJ1TEMS3PqQlzeXufne5-wXgSLEg5JS7TopY30F_yxweUe6ksRv7jHtCp6Z3eHBN-6PwchyNG3Ba98KU_BDzhJvRDGuvjYJzUSwoOc-LDsIV2-jrBdSGU7dz6ijqUUsdhd4xQiWKxhWrkKnimb_53Rd9AcxFmGr9TG8NnuoZluUlL53ZVHTSjx_kjf_8hXVYrfAn6ZYbZgMaKtuE5UF1wr4Fjw_PxQwH2Mo28orTJhNLwZkV5DkjMi9LZwjPJEFjaYpo3xXJ0fCkxKTVUWrEeEZJ8owMb7oesWwhJtNbbMOod35_1neqCxiM5HzmaMQuigoeiDhkro65lr6IAyY9tPCuSnmohQpcLT0ah4GvMFaTSpobwtFKnEgv2IGlLM_ULpCUa4G2TEdSY0gpJaciZEJI39ycpdhJEw5rUSSTkmcjqeMTXKbELlMTWrWQkkrViiRwWUxNR63fhGO72r9_IOkO7-zD3t-H7sOKj0CmTLu0YGn6NlMHCESmoo077uKqbffdJ6tZ2tk
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5kBfXiW1yfQTx46dJnTMHLIi7rY1V0VxZEStIkIEordteDv95J2q4PEMRbD2lJM5mZbyYzXwD2FQtCTrnrpIj1HfS3zOER5U4au7HPuCd0anqHe5e0OwjPhtFwCo7qXpiSH2KScDOaYe21UXCTkP6i5TwvWohXTKfvdEgxTjGQ6GZCHkU9asmj0D9GqEbRsOIVMnU8k1e_e6NPiPkVqFpP01mAh3qOZYHJU2s8Eq30_Qd9439_YhHmKwhK2uWeWYIplS3DTK86ZF-B-7vHYowDbHEbecZ5kxfLwpkV5DEjMi-rZwjPJEF7aepo3xTJ0fakxGTWUXDEOEdJ8oxcXbc9YglDTLK3WIVB56R_3HWqOxiM8HzmaIQvigoeiDhkro65lr6IAyY9NPKuSnmohQpcLT0ah4GvMFyTSppLwtFQHEovWINGlmdqHUjKtUBzpiOpMaqUklMRMiGkby7PUuywCXu1LJKXkmojqUMUXKbELlMTtmopJZW2FUngspiaplq_CQd2uX__QNK-urUPG38fuguz3X7vIrk4vTzfhDkfcU2ZhdmCxuh1rLYRl4zEjt1-Hz8o3gE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visual+field+loss+patterns+in+dominant+and+recessive+optic+atrophy+based+on+OPA1+archetypes&rft.jtitle=Acta+ophthalmologica+%28Oxford%2C+England%29&rft.au=Cascavilla%2C+Maria+Lucia&rft.au=Coutinho%2C+Catarina&rft.au=Battista%2C+Marco&rft.au=Zanchetta%2C+Ferdinando&rft.date=2024-01-01&rft.issn=1755-375X&rft.eissn=1755-3768&rft.volume=102&rft.issue=S279&rft_id=info:doi/10.1111%2Faos.16108&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_aos_16108
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-375X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-375X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-375X&client=summon